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Genetically Engineering Plants
for Crop Improvement
CHARLES S. GASSER AND ROBERT T. FRALEY
Dramatic progress has been made in the development of gene transfer systems for higher plants. The ability to introduce foreign genes into plant cells and tissues and to regenerate viable, fertile plants has allowed for explosive expansion of our understanding of plant biology and has provided an unparalleled opportunity to modify and improve crop plants. Genetic engineering of plants offers significant potential for seed, agrichemical, food processing, specialty chemical, and pharmaceutical industries to develop new products and manufacturing processes. The extent to which genetically engineered plants will have an impact on key industries will be determined both by continued technical progress and by issues such as regulatory approval, proprietary protection, and public perception.
T HE STABLE INTRODUCTION OF FOREIGN GENES INTO
plants represents one of the most significant developments in a continuum of advances in agricultural technology that includes modern plant breeding, hybrid seed production, farm mechanization, and the use of agrichemicals to provide nutrients and control pests. The first-generation applications of genetic engineering to crop agriculture are targeted at issues that are currently being addressed by traditional breeding and agrichemical discovery efforts: (i) improved production efficiency, (ii) increased market focus, and (iii) enhanced environmental conservation. Genetic engineering methods complement plant breeding efforts by increasing the diversity of genes and germplasm available for incorporation into crops and by shortening the time required for the production of new varieties and hybrids. Genetic engineering of plants also offers exciting opportunities for the agrichemical, food processing, specialty chemical, and pharmaceutical industries to develop new products and manufacturing processes.
The first transgenic plants expressing engineered foreign genes were tobacco plants produced by the use of Agrobacterium tumefaciens vectors (1). Transformation was confirmed by the presence of foreign DNA sequences in both primary transformants and their progeny and by an antibiotic resistance phenotype conferred by a chimeric neomycin phosphotransferase gene. These early transformation experiments often utilized plant protoplasts as the recipient cells; the subsequent development of transformation methods based on regenerable explants (2) such as leaves, stems, and roots contrib- uted significantly to the facile and routine transformation methods that are used today for many dicotyledonous plant species. A variety of free DNA delivery methods, including microinjection, electroporation, and particle gun technology are being developed for the transformation of monocotyledonous plants such as corn, wheat, and rice. In view of the rapid progress that is being made, it is likely that all major dicotyledonous and monocotyledonous crop species will be amenable to improvement by genetic engineering within the next few years.
In this article, we describe transformation methods that have been developed for plants and discuss some of the applications of genetically engineered plants in agriculture. We also address some of the critical issues that will influence the commercialization of genetically engineered crops.
Methods for Introducing Genes into Plants
Agrobacterium tumefaciens-mediated gene transfer. Derivatives of the plant pathogen Agrobacterium tumefaciens have proved to be efficient, highly versatile vehicles for the introduction of genes into plants and plant cells. Most transgenic plants produced to date were created through the use of the Agrobacterium system. Agrobacterium tumefaciens is the etiological agent of crown gall disease and produces tumorous crown galls on infected species. The utility of this bacterium as a gene transfer system was first recognized when it was demonstrated that the crown galls were actually produced as a result of the transfer and integration of genes from the bacterium into the genome of the plant cells (3). Virulent strains of Agrobacterium contain large Ti (for tumor inducing) plasmids, which are responsible for the DNA transfer and subsequent disease symptoms. Genetic and molecular analyses showed that Ti plasmids contain two sets of sequences necessary for gene transfer to plants; one or more T-DNA (transferred DNA) regions that are transferred to the plant, and the Vir (virulence) genes which are not, themselves, transferred during infection. The T-DNA regions are flanked by border sequences that were shown to be responsible for the definition of the region that is to be transferred to the infected plant cell. The T-DNA contains 8 to 13 genes (4), including a set for production of phytohormones, which are responsible for formation of the characteristic tumors when transferred to infected plants. Several excellent reviews on the biology of this and other pathogenic species of Agrobacterium have been published for those who desire more detailed information (4) .
Early experiments demonstrated that heterologous DNA inserted into the T-DNA could be transferred to plants along with the existing T-DNA genes (5). Efficient plant transformation systems were constructed by removing the phytohormone biosynthetic genes from the T-DNA region, thereby eliminating the ability of the bacteria to induce aberrant cell proliferation (6). Modern plant transformation vectors are capable of replication in Escherichia coli as well as Agrobacterium, allowing for convenient manipulations (7). The general features of these vectors and the process of transfer to plant cells are outlined in Fig. 1 . Recent technological advances in vectors for Agrobacterium-mediated gene transfer have involved improvements in the arrangements of genes and restriction sites in the plasmids that facilitate construction of new expression vectors. Vectors in current use have convenient multilinker regions, which may be flanked by a promoter and a polyadenylate addition site for direct expression of inserted coding sequences (8) .
Agrobacterium constitutes an excellent system for introducing genes into plant cells, since (i) DNA can be introduced into whole plant tissues, which bypasses the need for protoplasts, and (ii) the integration of T-DNA is a relatively precise process. The region of DNA to be transferred is defined by the border sequences; occasional rearrangements do occur, but in most cases an intact T-DNA region is inserted into the plant genome (9). This contrasts with free DNA delivery systems in which the plasmids routinely undergo rearrangment and concatenation reactions before insertion and can lead to chromosomal rearrangements during insertion in both animal (10) and plant (11) (1, 13) . Introduced traits have been found to be stable over at least five generations during cross-breeding and seed increase on genetically engineered tomato and oilseed rape plants (14) . This stability is critical to the commercialization of transgenic plants. The list of plant species that can be transformed by Agrobacterium has been greatly expanded and now includes several of the most important broadleaf crops (Table 1) 
Application of Genetic Engineering to Crop Improvement
The availability of efficient transformation systems for crop species is of intense interest to biotechnology, agrichemical, and seed companies for the application of this technology to crop improvement. Initial research has been focused on the engineering of traits that relate directly to the traditional roles of industry in farming, such as the control of insects, weeds, and plant diseases. Progress has been rapid, and genes conferring these traits have already been successfully introduced into several important crop species. Genetically engineered soybean, cotton, rice, corn, oilseed rape, sugarbeet, tomato, and alfalfa crops are expected to enter the marketplace between 1993 and 2000.
Weed control. Engineering herbicide tolerance into crops represents a new alternative for conferring selectivity and enhancing crop safety of herbicides. Research has largely concentrated on those herbicides with properties such as high unit activity, low toxicity, low soil mobility, and rapid biodegradation and with broad spectrum activity against various weeds. The development of crop plants that are tolerant to such herbicides would provide more effective, less costly, and more environmentally attractive weed control. The commercial strategy in engineering herbicide tolerance is to gain market share through a shift in herbicide use (33)-not to increase the overall use of herbicides, as is popularly held. Herbicide-resistant plants will have the positive impact of reducing overall herbicide use through substitution of more effective and environmentally acceptable products.
Two general approaches have been taken in engineering herbicide tolerance: (i) altering the level and sensitivity of the target enzyme for the herbicide and (ii) incorporating a gene that will detoxify the herbicide. As an example of the first approach, glyphosate, the active ingredient of Roundup herbicide, acts by specifically inhibiting the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) (34). Glyphosate is active against annual and perennial broadleaf and grassy weeds, has very low animal toxicity, and is rapidly inactivated and degraded in all soils (35) . Tolerance to glyphosate has been engineered into various crops by introducing genetic constructions for the overproduction of EPSPS (36) or of glyphosate-tolerant variant EPSPS enzymes (37, 38). Similarly, resistance to sulfonylurea compounds, the active ingredients in Glean and Oust herbicides, has been produced by the introduction of mutant acetolactate synthase (ALS) genes (39). Glean and Oust are broad-spectrum herbicides and are effective at low application rates. Since both EPSPS and ALS activities are present in wild-type plants, the possibility of deleterious effects on crop performance or product quality due to their reintroduction is unlikely. The use of these herbicides in new crop applications may require reexamination of residues of the herbicides; however, since the residue safety levels for these two compounds in food crops have already been established, this is not an issue unique to genetically engineered plants.
Resistance to gluphosinate (40) and bromoxynil (41) has been achieved by the alternative approach of introducing bacterial genes 16 JUNE 1989 encoding enzymes that inactivate the herbicides by acetylation or nitryl hydrolysis, respectively. In field tests the gluphosinate-tolerant plants have shown excellent tolerance to the herbicide (42). Evaluation of the biological activity of the specific herbicide conjugates and metabolites that may be present in the transgenic plants will be carried out according to existing chemical residue regulations.
Current crop targets for engineered herbicide tolerance include soybean, cotton, corn, oilseed rape, and sugarbeet. Factors such as herbicide performance, crop and chemical registration costs, potential for out-crossing to weed species, proprietary rights issues, and competing herbicide technologies must all be considered before final decisions on commercialization of specific herbicide-tolerant crops can be made.
Insect The excellent insect control observed under field conditions indicates that this technology may have commercial application in the near future. Early market opportunities for caterpillar resistance are leafy vegetable crops, cotton, and corn. Crop targets for beetle resistance are potato and cotton. Other types of insecticidal molecules are necessary to extend biotechnology approaches for controlling additional insect pests in these and other target crops. Plants genetically engineered to express a proteinase inhibitor gene are partially resistant to tobacco budworm in laboratory experiments (50); field tests will be necessary to determine the agronomic utility of this approach.
Disease resistance. Significant resistance to tobacco mosaic virus (TMV) infection, termed "coat protein-mediated protection," has been achieved by expressing only the coat protein gene of TMV in transgenic plants (51). This approach produced similar results in transgenic tomato, tobacco, and potato plants against a broad spectrum of plant viruses, including alfalfa mosaic virus, cucumber mosaic virus, potato virus X, and potato virus Y (52). One mechanism of coat protein-mediated cross protection appears to involve interference with the uncoating of virus particles in cells before translation and replication (53).
Transgenic tomatoes carrying the TMV coat protein gene have been evaluated in greenhouse and field tests and shown to be highly resistant to viral infection (Fig. 2) (54) . The transgenic plants showed no yield loss after virus inoculation, whereas the yield was reduced 23% to 69% in control plants. The anaerobiosis, wounding, nutrients, and applied phytohormones, have been isolated and characterized (60). The control regions of these genes may also find utility in genetic engineering strategies.
The ability to decrease the expression of a gene in a transgenic plant also has potential utility in the study of plant gene expression and function as well as in crop improvement. Significant successes have already been achieved with genes that produce antisense RNAs to the messengers for polygalacturonase in tomato fruits (61) and chalcone synthase in petunia and tobacco plants (62) . In all of these studies, substantial reductions (up to 90%) in the levels of the mRNA and protein products of the target genes were observed. Striking phenotypic alterations were observed in some of these transgenic plants (62) . This method of constructing mutant phenotypes will significantly enhance biochemical and physiological studies on protein and enzyme function. In an alternative approach to reducing expression of a gene, the enzymatic regions derived from self-splicing RNA molecules are used to design RNA enzymes capable of specific RNA cleavage (63) . In vitro studies have demonstrated the potential of this method, but it has yet to be applied in plants (63) . Preliminary work on insertion of donor DNA into plant chromosomes by homologous recombination (64) 
Key Issues Affecting Introduction of Genetically Engineered Plants
The advances in crop improvement by genetic engineering have occurred so rapidly that the initial introduction of these crops in the marketplace will be primarily influenced by nontechnical issues. These issues include regulatory approval, proprietary protection, and public perception.
Regulatory approval. In the United States, genetically engineered plants potentially come under the statutory jurisdiction of three federal agencies: the United States Departmlent of Agriculture (USDA), Food and Drug Administration (FDA), and Environmental Protection Agency (EPA). The field testing of genetically engineered crops has been less controversial than the introduction of other recombinant organisms into the environment. In the last 3 years there have been over a dozen tests of engineered crops in diverse locations across the United States (72)-by year end there will be over 30 such tests. All of these tests have been reviewed in detail by the USDA, with input from the other government agencies. The key consideration in approval of these tests has been a scientific evaluation of the risk and environmental impact of a particular field test experiment. Several studies and discussions of the issues and perceptions that surround the release of genetically engineered crops have produced a consensus that such engineered crops present virtually no direct risk to human or animal health (73). The specific knowledge of the introduced DNA sequences, the detailed understanding of the known functions of the gene products, and the high level of biological or physical containment were cited as key reasons for the inherent low risk to human and animal health.
The "success" of such small field tests, while important, has overshadowed other needs in the regulatory process. For example, many unanswered questions remain regarding the cost and regulatory requirements for large-scale multisite field tests. It is important that an approval process be developed to accommodate the rapid transition that will occur as testing of engineered crops goes from small, isolated field plots to large-scale, multisite testing; the development of genetically engineered crop varieties and hybrids will ultimately occur in the fields around the world-not in the research laboratory. The mechanism for FDA or EPA approval or endorsement of genetically engineered plants and food products remains undefined. Issues such as regulatory requirements, registration costs, and commercialization timelines are already becoming significant issues for companies attempting to develop improved genetically engineered crops for te mid- Despite this background, recent polls conducted by the Office of Technology Assessment indicate that most people believe that the benefits of agricultural biotechnology research outweigh remote risks (72) . In view of the initial public debate that has occurred over the last several years on field testing and environmental release of genetically engineered organisms, it would seem that agricultural biotechnology has indeed passed its first major public perception obstacle.
The next test of the public acceptance of this technology will come in several years when food products derived from genetically engineered crops enter the general food supply. The current focus on issues of risk and environmental release has heightened the need for increased science education and open discussion of issues. It is essential that the safety and benefits of agricultural biotechnology research and the critical role that it will play in providing for world food demand (80) be communicated and understood, so that informed decisions by the public are possible.
A Future Perspective on Genetically Engineered Plants
During the last 5 years, the availability of gene transfer systems has catalyzed a major refocusing on plants as a biological system; the use of genetically engineered plants as an analytical tool to explore unique aspects of gene regulation and development and the potential to produce novel commercial crop varieties has created a high level of scientific excitement and has driven research into many new areas. The breadth of information to be gained from the study of transgenic plants is serving as an important focus for unifying basic plant science research in plant breeding, pathology, biochemistry, and physiology with molecular biology. Regulation of gene expression is the fundamental basis for manipulating cellular metabolism, and this new research tool offers the possibility of extending physiological and genetic observations to a mechanistic level. In the next few years we can expect to see major advances in our understanding of basic plant processes.
These advances, in turn, will accelerate the application of genetically engineered plants in the seed production and agrichemical industries. The major crops that can currently be improved with genetic techniques are soybean, cotton, rice, and alfalfa (Table 1) , and commercial introductions of genetically engineered varieties are likely in the mid-1990s. Rapid progress is being made in the genetic engineering of corn, and it is likely that genetically engineered corn 1298 hybrids carrying traits for resistance to herbicides, insects, and viral diseases will reach the marketplace by the year 2000. The timing of commercialization of genetically engineered crops is ultimately determined by the need to address each of the following issues: (i) evaluation of field performance, (ii) breeding and seed increase for commercial-scale release, (iii) establishment of optimal agronomic practices, and (iv) regulatory approval and crop certification.
The worldwide agrichemical industry has been and will continue to be a leading sponsor of agricultural biotechnology research. All major agrichemical companies have R&D efforts in the area of biotechnology for crop improvement. These companies see opportunities to develop new products and extend the use of existing products, as well as to be positioned at the leading edge of new technologies that may have a significant impact on existing agrichemical businesses.
Genetic engineering of plants also offers exciting opportunities for the food processing industry to develop new products and more cost-effective processes. While many of the early successful examples of genetically engineered plants have focused on agronomic genes, it is possible that the food processing and specialty chemical industries may represent the greatest commercial opportunity for biotechnology. Examples of such applications include production of (i) larger quantities of starch or specialized starches with various degrees of branching and chain length to improve texture and storage properties, (ii) higher quantities of specific oils or the elimination of particular fatty acids in seed crops, and (iii) proteins with nutritionally balanced amino acid composition. The ability to reduce processing costs by the elimination of anti-nutritive or off-flavor components in foods is quite feasible with antisense nucleic acid technology. The enzymes and genes involved in biosynthesis of coloring materials and flavors are important to the food industry and to the consumer. Studies on the biosynthesis of some of these compounds have been hampered by the low quantities of enzymes present in the producing cells, but new techniques based on gene tagging may overcome these difficulties.
Enormous opportunity lies in the successful use of crops for both commodity and specialty chemical products. Plants have traditionally been a source of a wide range of polymeric materials. These range from starch and celluloses, which are carbohydrate-based, to polyhydrocarbons such as rubber and waxes. Many of these polymers have been replaced in the last two to three decades by synthetic materials derived from petroleum-based products. However, the cost, supply, and waste-stream problems often associated with petroleum-based products are issues that are focusing renewed attention on the use of biological polymers. Genetic engineering will significantly enlarge the spectrum and composition of available plant polymers.
Plants also offer the potential for production of foreign proteins with various applications to health care. Proteins such as neuropeptides, blood factors, and growth hormones could be produced in plant seeds, and this may ultimately prove to be an economical means of production. Several mammalian proteins have been produced in genetically engineered plants (81), and expression of pharmaceutical peptides in oilseed rape plants has been reported (82).
